Tobramycin Sulfate Injection 80 Milligrams
Tobramycin 40mg
Prescription medication
Alvogen Korea Co., Ltd.
MFDS item code 198800705 · Notified 1988.09.27 · Insurance code 652601623
Treatment of systemic and localized infections (e.g., pneumonia, sepsis) and eye infections (e.g., conjunctivitis)
When used as an injection, this medication is effective in treating infections caused by various bacteria, including Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus. It is frequently used for central nervous system infections like meningitis, respiratory infections such as bronchitis and pneumonia, gastrointestinal infections like peritonitis, as well as skin and soft tissue infections. Additionally, it is utilized for treating post-surgical wound infections, osteomyelitis, sepsis, pyelonephritis, and severe urinary tract infections. In the form of eye drops or ophthalmic ointment, it is primarily used to treat ophthalmic infections such as conjunctivitis, keratitis, and dacryocystitis. This drug is widely used for treating various infectious diseases and improves infected areas.
(Injection) Adults: For severe infections, administer tobramycin 3mg (potency) per Kg of body weight per day in 3 divided doses by intravenous or intramuscular injection. For life-threatening infections, up to 5mg (potency) per Kg of body weight per day may be administered in 3~4 divided doses; when symptoms improve, the dose should be reduced to 3mg (potency) per Kg of body weight per day. Do not administer more than 5mg (potency) per Kg of body weight per day without measuring serum concentrations. The treatment period is usually 7~10 days and may be extended depending on the severity of the infection; in such cases, monitor renal, vestibular, and auditory function (neurotoxicity occurs more frequently when the treatment period is longer than 10 days.). Patients with renal impairment Measure the serum concentration of this medicine if possible. Administer an initial dose of 1mg (potency) per Kg of body weight, then reduce the dose or extend the dosing interval from the second dose onward. If the serum concentration of this medicine cannot be measured directly, calculate the dose based on creatinine clearance or serum creatinine concentration, and adjust the dose while monitoring the patient's condition. However, these methods should not be used during dialysis. 1) Dose reduction (dosing interval: 8 hours): If creatinine clearance is 70mL/min or less, or if the serum creatinine concentration is known, calculate the dose by multiplying the dose for a patient with normal renal function by the applicable % value in <Table 1>. If the patient's steady-state serum creatinine concentration is known, an approximate dose can be calculated by dividing the dose for a patient with normal renal function by the serum creatinine concentration. 2) Extended dosing interval (same dose as for patients with normal renal function): If the patient's creatinine clearance cannot be measured and the patient's condition is stable, administer doses at intervals in hours calculated by multiplying the serum creatinine concentration by 6. Adjust the dose appropriately according to age and symptoms. <Preparation of this medicine> For intramuscular injection, dissolve in 1.5mL of normal saline injection or water for injection before use. For intravenous injection in adults, dilute the dose in 50~100mL of normal saline injection or 5% dextrose injection and administer by intravenous drip over 20~60 minutes. (Eye drops) For mild to moderate infections, instill 1~2 drops into the infected area every 4 hours. For severe infections, instill 2 drops every hour until symptoms improve, then gradually reduce and discontinue. Adjust the dose appropriately according to age and symptoms. (Ophthalmic ointment) For mild to moderate infections, apply approximately 1cm to the infected area 2~3 times daily. For severe infections, apply 1cm to the infected area every 3~4 hours until symptoms improve, then gradually reduce and discontinue. Adjust the dose appropriately according to age and symptoms.
Children: Administer 5mg (potency) per Kg of body weight per day in 3~4 divided doses by intravenous or intramuscular injection. Neonates (less than 1 week old): Administer 4mg (potency) per Kg of body weight per day in divided doses every 12 hours. For intravenous administration in children, reduce the volume of diluent proportionally. Intravenous infusion over less than 20 minutes may cause the serum tobramycin concentration to exceed 12mg/mL and should be avoided; it is preferable not to administer this medicine mixed with other medicines.
This drug is an aminoglycoside antibiotic primarily used for the treatment of infections and should be avoided in certain patients. First, it should not be administered to patients who have had allergic reactions to this drug or similar components. Additionally, it is not safe for patients with ear diseases, severe kidney dysfunction, pregnant or breastfeeding women, patients with muscle disorders, patients with bronchial asthma, or patients with disorders of the 8th cranial nerve. Patients with renal or hepatic dysfunction, a family history of hearing loss or existing hearing loss, newborns and premature infants, elderly individuals, and patients with poor nutritional status should be monitored particularly while using this drug, and regular blood drug concentration and hearing tests should be performed as necessary. This drug can induce allergic reactions; therefore, allergy status should be confirmed prior to use, and if symptoms such as rash, itching, or difficulty breathing occur, administration should be stopped immediately. Rarely, serious side effects may include shock, worsening of kidney function, hearing loss, and neurological symptoms, so if these symptoms occur, immediate consultation with medical personnel is required. Moreover, combining this drug with certain other medications may enhance nephrotoxic effects or neuromuscular blockade; thus, it is essential to inform about other medications being taken, especially anesthetics, muscle relaxants, diuretics, and anticoagulants. During pregnancy, there is a risk of fetal nerve damage, so it should only be used when necessary and under a doctor's judgment, and during breastfeeding, it is advisable to discontinue administration since this drug can be passed into breast milk. In children or the elderly, dosing adjustments and careful observation are necessary as their renal function may be weaker. In case of overdose, kidney impairment, hearing, and vestibular disturbances, and respiratory paralysis may occur, and treatments such as dialysis may be required. This drug should not be mixed with β-lactam antibiotics when injected, as efficacy may diminish, and patients wearing contact lenses should avoid wearing them during treatment. Finally, to prevent the development of resistant bacteria, it is crucial to administer this drug only for the appropriate duration based on susceptibility testing, and long-term use should be approached with caution regarding the overgrowth of resistant bacteria.
shock
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to avoid contact with air and should be kept in a cool, room temperature location away from direct sunlight.
A colorless to light yellow transparent liquid contained in vials or ampoules
50 ampoules (2mL/ampoule x 50)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tobramycin 40mg
Prescription medication
Alvogen Korea Co., Ltd.
Tobramycin 40mg
Injections · Prescription medication
(Co., Ltd.) Daewoong Pharmaceutical
Tobramycin 300mg
Eye drops · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Tobramycin 50mg
Injections · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Tobramycin 3mg
Eye drops · Prescription medication
Samchundang Pharmaceutical Co., Ltd.
Tobramycin
Prescription medication
You & Life Science Co., Ltd.
Tobramycin 3mg
Eye drops · Prescription medication
Hanlim Pharmaceutical Co., Ltd.
Tobramycin
Prescription medication
Anguk Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.